| CAS No. | CATO-C4X-109935 |
| Molecular Formula | C5H14Cl2N2 |
| Molecular Weight | 173.08 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Compared with other compounds in its class, the molecular weight of 173.08 g/mol gives Alogliptin Impurity 35 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
As a process- or degradation-related impurity, Alogliptin Impurity 35 (CAS CATO-C4X-109935, C5H14Cl2N2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Structurally, Alogliptin Impurity 35 (C5H14Cl2N2) contains chlorine substitution. The molecule exhibits a degree of unsaturation (DBE) of -1.0, corresponding to approximately 0 ring(s) or double-bond equivalent(s). With a molecular weight of 173.08 g/mol, it falls into the medium-molecular-weight range. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Alogliptin Impurity 35 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C5H14Cl2N2 |
| Molecular Weight | 173.08 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | -1.0 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |